Close Menu

NEW YORK (GenomeWeb) – Bruker reported after the close of the market Thursday that revenues in the third quarter grew 7 percent year over year.

For the three months ended Sept. 30 total revenues rose to $466.6 million from $435.6 million in Q3 2017, beating the consensus Wall Street estimate of $451.7 million.

The company saw a 1.5 percent positive effect from acquisitions and a 1.4 percent negative effect from currency effects on the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries.